1. Home
  2. HURN vs MANE Comparison

HURN vs MANE Comparison

Compare HURN & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huron Consulting Group Inc.

HURN

Huron Consulting Group Inc.

N/A

Current Price

$124.94

Market Cap

2.2B

ML Signal

N/A

MANE

Veradermics Incorporated Common Stock

N/A

Current Price

$63.61

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HURN
MANE
Founded
2002
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.8B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
HURN
MANE
Price
$124.94
$63.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$215.50
$78.33
AVG Volume (30 Days)
292.4K
281.6K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
5.84
N/A
Revenue
$1,699,143,000.00
N/A
Revenue This Year
$11.74
N/A
Revenue Next Year
$10.55
N/A
P/E Ratio
$22.27
N/A
Revenue Growth
11.65
N/A
52 Week Low
$116.12
$36.26
52 Week High
$186.78
$63.03

Technical Indicators

Market Signals
Indicator
HURN
MANE
Relative Strength Index (RSI) 34.33 76.56
Support Level $118.18 $39.73
Resistance Level $138.06 N/A
Average True Range (ATR) 4.92 4.26
MACD 0.09 0.92
Stochastic Oscillator 1.08 88.20

Price Performance

Historical Comparison
HURN
MANE

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About MANE Veradermics Incorporated Common Stock

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Share on Social Networks: